William Lis
2014 - Portola Pharmaceuticals
In 2014, William Lis earned a total compensation of $3.4M as Chief Executive Officer at Portola Pharmaceuticals, a 138% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $267,750 |
|---|---|
| Option Awards | $2,632,812 |
| Salary | $450,000 |
| Other | $2,000 |
| Total | $3,352,562 |
Lis received $2.6M in option awards, accounting for 79% of the total pay in 2014.
Lis also received $267.8K in non-equity incentive plan, $450K in salary and $2K in other compensation.
Rankings
In 2014, William Lis' compensation ranked 2,641st out of 13,032 executives tracked by ExecPay. In other words, Lis earned more than 79.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,641 out of 13,032 | 80th |
Division Manufacturing | 940 out of 4,966 | 81st |
Major group Chemicals And Allied Products | 292 out of 1,686 | 83rd |
Industry group Drugs | 228 out of 1,365 | 83rd |
Industry Pharmaceutical Preparations | 188 out of 1,043 | 82nd |
Source: SEC filing on April 24, 2017.
Lis' colleagues
We found two more compensation records of executives who worked with William Lis at Portola Pharmaceuticals in 2014.